TUMS U.S. SALES RISE 18% IN SECOND QUARTER
This article was originally published in The Tan Sheet
Executive Summary
TUMS U.S. SALES RISE 18% IN SECOND QUARTER and market share for the antacid increased to 48.2%, up four share points since SmithKline Beecham reported first quarter results in April and more than double the share held by the number two brand, according to the company. SmithKline attributed the continued growth of the Tums line to effective advertising and the recent launch of the Tums 500 chewable calcium supplement product.